Andrew Guggenhime, PRESIDENT AND CFO at Vaxcyte, Inc. (PCVX), sold 15,652 shares at $71.89 ($1.1M) on 2024-06-18, disclosed to the SEC on 2024-06-20.
Scheduled sale ($1.1M) by PRESIDENT AND CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.89 | 7,652 | $550K | 48.9% |
| 2 | $71.89 | 7,652 | $550K | 48.9% |
| 3 | $72.56 | 348 | $25K | 2.2% |
| Total | $71.90 avg | 15,652 | $1.1M | 100% |
| Filing → |
| PCVX | SELL | 2026-06-18 | $530K | — | Filing → |
| PCVX | SELL | 2025-02-19 | $1.3M | — | Filing → |
| PCVX | SELL | 2025-01-22 | $1.4M | — | Filing → |